‘This is my passion. It started out personal to me; it still is, extremely so,' said Dr Cross. Dozens of drugs to slow cognitive decline in dementia over the past decade have failed to show a real ...

Work could lead to the discovery of new therapeutic targets. For the first time, researchers have identified "molecular ...

Memory loss is the most well-known symptom of dementia, particularly Alzheimer’s disease. But experts say there are other ...

An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer’s ...

Professor David Dexter, director of research at Parkinson ... of the pathology through the brain and then causes the ...

More than 70% of dementia cases are not diagnosed in time for patients to receive treatment, but new technology is turning ...

A new analysis of classical medical texts suggests dementia was extremely rare in ancient Greece and Rome 2,000 to 2,500 ...

Researchers have developed a molecule called LaKe that mimics the metabolic effects of strenuous exercise and fasting.

AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.

One of the major breakthroughs over the last couple of years has been a potential new diagnostic test for Parkinson’s – a ...

The Triangulation of Innovative Methods to End Alzheimer's Disease project will use large, diverse datasets to examine whether interventions targeting alcohol use, depression, vision or hearing ...

According to Alzheimer’s Disease International and Dementia Forecasting Collaborators, Alzheimer’s Disease is currently the ...